Con­ti­nu­ity and di­ver­si­ty: Rafaèle Tord­j­man's women-led VC firm tops out first fund at $630M

For a first-time fund, Jeito Cap­i­tal talks a lot about con­ti­nu­ity.

Rafaèle Tord­j­man had spot­light­ed that con­cept ever since she start­ed build­ing the firm in 2018, promis­ing to go the ex­tra mile(s) with biotech en­tre­pre­neurs while push­ing them to reach pa­tients faster.

Co­in­ci­den­tal­ly, the lack of con­ti­nu­ity was one of the sore spots list­ed in a re­port about the Eu­ro­pean health­care sec­tor pub­lished that same year by the Eu­ro­pean In­vest­ment Bank — whose fund is one of the LPs, along­side the Amer­i­can pen­sion fund Teacher Re­tire­ment Sys­tem of Texas and Sin­ga­pore’s Temasek, to help Jeito close its first fund at $630 mil­lion (€534 mil­lion). As pre­vi­ous­ly re­port­ed, Sanofi had chimed in €50 mil­lion, mark­ing its first in­vest­ment in a French life sci­ences fund.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER